Evofem Biosciences, Inc.
San Diego, United States
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Evofem Biosciences, Inc was founded by Alexander A. Fitzpatrick, Kelly J. Cullwell, Gillian Greer, Thomas Lynch, Russell J. Barrans, Justin J. File, William Hall, Kelly J. Culwell, Justin J File, Russell J Barrans, Kelly J Culwell, Tony O'Brian, Justin File, Jenny Yip, Tony O'Brien, Colin Rutherford, Saundra Pelletier, Kim Kamdar, William P. Hall, Kim P. Kamdar, Lisa A. Rarick, Tony P. O'Brien, Lisa Rarick and Ivy Zhang, and is based in San Diego, United States.
Key facts
- Industry
- Biotechnology
- Legal form
- Incorporated in Delaware
- Listed
- OTC · EVFM
About
Pharmaceutical Preparations; formerly Neothetics, Inc.; listed on OTC as EVFM; filing with the SEC since 2014
Founders
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
In context
We hold 2,331 other biotechnology companies. None has a closure on record yet. Of the 2,210 that report what they raised, the median is $3,512,633.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment